Op-Ed by Lezlee Westine, President & CEO, Personal Care Products Council, on Senate Appropriations Act

This op-ed originally appeared in Real Clear Policy on Sept. 12, 2023.

Congress: Fund the FDA to Fully Bring Cosmetics Reform to Life

Cosmetics and personal care products companies provide American consumers with safe, effective products that enhance their health, well-being and overall quality of life. Whether for toothpaste, cleansing and moisturizing products or color cosmetics, the Personal Care Products Council (PCPC) and our member companies are firmly committed to ensuring safe and effective products through robust scientific research and development. 

For more than a decade, PCPC and our members have advocated for federal regulatory cosmetics reform by the U.S. Food and Drug Administration (FDA). The 2022 passage of the Modernization of Cosmetics Regulation Act (MoCRA) modernizes FDA oversight of cosmetics and personal care products, and creates a comprehensive and uniform national framework for regulating these products.  This landmark legislation gives the FDA significant new authorities and regulatory tools that promote product safety and preserve innovation for the science-driven beauty and personal care industry and reinforces consumer confidence in products they trust and enjoy every day. 

Although PCPC member companies have long provided more product information than is required by law, manufacturers are now obligated to maintain records of adverse events and report serious events under MoCRA. Facilities producing cosmetics in the U.S. must register with the FDA, listing each product, its ingredients and manufacturing location. They are also required to substantiate the safety of their products through well-documented records. Product labels must identify potential allergens and include contact information to report potential adverse events. MoCRA also gives the FDA new enforcement capabilities, including the authority to suspend a facility’s registration and recall products that may pose a serious health risk.

But our work is not done. The FDA needs funding to implement these critical provisions. PCPC’s message to Capitol Hill is clear and urgent: we support the $7 million in the Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act to empower the FDA to fully implement MoCRA. Together with the Professional Beauty Association and its more than 100,000 members, we are calling on Congress to help the FDA realize the full potential of MoCRA and its public health mission. A lack of funding now would undermine more than a decade of bipartisan effort. 

The beauty and personal care industry is dedicated to consumer safety, product innovation and scientific excellence. We urge Congress to act quickly to provide the FDA with the resources it needs to fulfill MoCRA’s promise. Now is the time to make this promise a reality.

Op-Ed by Lezlee Westine, President and CEO Personal Care Products Council, on Cosmetics Reform

This op-ed originally appeared in The Opinion Pages on Dec. 1, 2022.

The Time for Cosmetics Reform is Now

Every day, millions of Americans use a variety of beauty and personal care products to enhance their lives — from sunscreen, toothpaste and shampoo to moisturizer, makeup and fragrance. The Personal Care Products Council (PCPC) and its member companies are proud of the trust consumers place in our products. We take our responsibility to provide safe, high-quality products very seriously. Consumer and product safety are our top priorities, with careful and thorough scientific research and development serving as the foundation for everything we do.

Our sector has a long history of going above and beyond what is required by law. However, we recognize that the current oversight of our industry by the U.S. Food and Drug Administration (FDA) was created more than 80 years ago under the Food, Drug and Cosmetic Act of 1938.

It is time to bring personal care products regulation into the 21st century to reflect our dynamic, innovative and science-based industry. We firmly believe that well-crafted reforms, grounded in the best available science will provide the FDA with the appropriate tools to oversee our rapidly growing industry, help us continue innovating, and further strengthen consumer confidence in the products they trust and enjoy every day.

For more than a decade, PCPC and its member companies have worked with members of Congress, consumer and health care advocates, and other key stakeholders to reach bipartisan consensus to support a contemporary approach to cosmetics oversight. We applaud members of Congress for their work on the Modernization of Cosmetics Regulation Act (MoCRA). This legislation will create a legislative framework that will bolster companies’ ability to innovate and enhance consumer confidence in the products they use and love.

Additionally, our sector contributes significantly to the U.S. economy. The beauty and personal care products industry provides 3.9 million domestic jobs and touches nearly every state, city and county. Women compromise 77% of our workforce. Our industry employs and consults with thousands of scientific, medical and technical experts devoted to studying the human and environmental impacts of our products and their ingredients. An updated, sensible regulatory approach can give these companies — 70% of them small businesses — the regulatory certainty they need to compete, grow and contribute to our nation’s economy, while ensuring consumers that their safety is protected and providing full transparency about the manufacture of their products.

We urge Congress to pass legislation to create a more modernized regulatory system for the beauty and personal care sector — one that will advance product safety and innovation and reinforce consumer trust. Now is the time to act.

Op-Ed by Lezlee Westine, President and CEO Personal Care Products Council, on Modernizing the FDA to Protect Cosmetics Users

This op-ed, authored by Lezlee Westine, President and CEO, Personal Care Products Council, originally appeared in RealClearPolicy on March 4, 2019.

Millions of American families use cosmetics and personal care products every day. From toothpaste, sunscreen and lipstick to deodorant, shampoo and moisturizer, these products are used to promote the beauty, health and well-being of consumers. We hold sacred the trust that families put in the safety and effectiveness of our products. That is why cosmetics and personal care product companies are committed to product safety and scientific innovation. We want families to have continued confidence in our products.

Decades of consumer experience with our products demonstrate they are among the safest product categories regulated by the U.S. Food & Drug Administration (FDA). FDA has clear authority — today — to regulate the safety of these products under the federal Food, Drug & Cosmetic Act, which requires companies to substantiate that every product and each individual ingredient is safe and that the label on the product is not misleading before the product is made available to consumers. It’s a company’s clear, legal responsibility to ensure that its products comply with the law and the current law provides penalties for manufacturers that do not meet these standards.

Nevertheless, we are working under a 20th century regulatory system for 21st century products. That doesn’t make sense.

The Personal Care Products Council (PCPC) and its member companies support modernizing the Food, Drug & Cosmetics Act to ensure FDA has the appropriate authority and resources to regulate cosmetic products in the 21st century. We believe well-crafted reforms will support the industry’s ability to innovate and further strengthen consumer confidence in our products.

For more than a decade, PCPC and its member companies have worked with a bipartisan group of leaders in Congress and a diverse group of interested parties to create a more contemporary regulatory system for the cosmetics and personal care sector. Our commitment to reform has not wavered, and we believe regulations should be based on the best available science and applied on a consistent basis nationwide to enhance our ability to innovate and further strengthen consumer confidence in the products they trust and enjoy every day.

Our member companies support a set of principles that guide our support of bipartisan legislation. These principles include:

  • A science-based national regulatory system for cosmetics ensures safe products in the marketplace, eliminates consumer confusion, gives entrepreneurs greater certainty and makes it possible to innovate and create jobs.
  • Legislation to modernize the FDA should create a program that authorizes FDA to review the safety of individual cosmetic ingredients. This will further strengthen consumer confidence.
  • Manufacturers should be required to report to the FDA serious and unexpected adverse health events experienced by a consumer of cosmetic products.
  • The FDA should have the authority to order a mandatory recall of a product if it is adulterated or causes serious adverse health consequences.
  • Finallysmall businesses must be given flexibility to meet the new reforms. These should allow flexibility for small businesses, as defined by the Small Business Administration, to comply with certain requirements, including additional time to submit ingredient statements to FDA, simplified ingredient statements, additional FDA guidance on safety substantiation, and extended effective date for GMP compliance. Very small cosmetic manufacturers (those making less than $2 million in gross receipts annually in the U.S.) should be entirely exempted from any new requirements. Small businesses are the backbone of our nation’s economy and a primary source for innovation. They should not be put under undue pressure that could jeopardize their business.

Regulators, legislators, nongovernmental organizations and industry are all on the same side when it comes to modernizing the FDA. We urge Congress to pass bipartisan legislation that meets our mutual goal — creating a regulatory system that advances safety, innovation and consumer confidence.